Beyfortus 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FP8LV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,840
Award facts
- Contract value 100% obligated
- $14,840.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 8, 2026, represents a $14.8K purchase of Beyfortus 100 mg/mL syringes by the Defense Logistics Agency (DLA) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The order is structured as a firm fixed-price contract with an ultimate completion date of January 9, 2026, and involves no set-aside designation, indicating open competition. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $1 billion through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., functions as a critical pharmaceutical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Beyfortus (respiratory syncytial virus monoclonal antibody) is a specialized pharmaceutical product used for respiratory protection, reflecting DLA's broader mandate to supply essential medications and medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FP8LV?
SPE2DR26FP8LV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FP8LV worth?
The government has obligated $14,840 on SPE2DR26FP8LV.
Is contract SPE2DR26FP8LV an order under another contract?
Yes. SPE2DR26FP8LV is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8LV competed?
The extent of competition for SPE2DR26FP8LV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award